factual
Regulator Knew of Harm and Did Not Act
Internal GlaxoSmithKline memos, leaked via a peer reviewer who faxed Nissen's manuscript to the company, revealed that GSK had already done its own meta-analysis of the unpublished data showing Rosiglitazone increased heart attacks and had shared it with the FDA, yet no regulatory decision changed—a case where the regulator had access to the full data or its meta-analysis and did not alter its stance.
factualpending
Speaker
Jacob StegengaEvidence Quote
“It suggested that Glaxo Smith Kline had already done their own meta-analysis based on this unpublished data. And, they'd shared that information with the FDA. And, that no regulatory decision had been made after that.”
Created: 6/13/2026, 12:09:58 AM
Your notes
Loading notes...